Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-06 · accession 0001650131-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-11 | 2026-03-06 | MIRM | Radovich Peter | Pres AND COO | M - OptEx | $15.87 | +5,912 | 26.6K | +29% | +$93.8K |
| D | 2026-03-11 | 2026-03-06 | MIRM | Radovich Peter | Pres AND COO | M - OptEx | $0.00 | -5,912 | 54.1K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-06 | M | A | 5,912 | $15.87 | 26,567 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2026-03-06 | M | D | 5,912 | $0.00 | 54,088 | D | $15.87 · — to 2032-01-05 | 5,912 Common Stock | (F1) The stock option is fully vested. |